Loading patent…
AssigneeMetabolon, Inc.
InventorsRegis Perichon, Lauren Nicole Bell, Jacob Wulff, Uyen Thao Nguyen, Steven M. Watkins
Estimating the term…
Biomarkers of NASH, NAFLD, and fibrosis and methods for diagnosis (or aiding in the diagnosis) of NAFLD, NASH and/or fibrosis are described herein. Additionally, methods of distinguishing between NAFLD and NASH, methods of classifying the stage of fibrosis, methods of determining the severity of liver disease, methods of determining the severity of liver disease or fibrosis, and methods of monitoring progression/regression of NASH, NAFLD, and/or fibrosis are described herein.
1-37. (canceled)
A method of diagnosing or aiding in diagnosing whether a subject has liver disease, comprising:
A method of determining the fibrosis stage of a subject having liver fibrosis, comprising:
A method of monitoring progression/regression of liver disease in a subject comprising:
Dependencies are inferred from the claim text.